Does adding a cleaning step to wound vacs help severe infections?
NCT ID NCT07120386
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests two types of wound vacuum therapy for people with severe, flesh-eating infections. One method just uses suction, while the other also cleans the wound with a dilute bleach solution. Researchers want to see if the cleaning method leads to fewer hospital readmissions and faster healing. The trial will enroll 30 adults and is a first step to see if a larger study is possible.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Negative pressure wound therapy with or without instillation (hypochlorous acid)
- What this could lead to
- If NPWTi proves better, it could reduce hospital readmissions and speed up wound healing for people with severe infections.
- What could go wrong
- This is a small pilot study with only 30 people, so results may not be conclusive. The instillation adds a step and may not improve outcomes over standard therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2025
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Clinical suspicion for Necrotizing Soft Tissue Infection (NSTI) necessitating emergent operative intervention * Age \>/=18 years old * Planned application of a negative pressure wound dressing Exclusion Criteria: * Patients who have a wound that does not allow for a wound vac * Patients receiving acute treatment for a NSTI at another institution * Incarcerated patients * Patients who do not survive to wound closure/coverage * Patients \<18 years old
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Necrotizing soft-tissue infections are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Regions Hospital
RECRUITINGSaint Paul, Minnesota, 55101, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.